Register for Digital Look

ImmuPharma says not looking to raise funds

By Michele Maatouk

Date: Wednesday 11 Dec 2019

(Sharecast News) - AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds.
In a brief statement, the company noted the volatility in its share price following the recently-announced licensing and development agreement with US speciality pharmaceutical group Avion - which will see Avion will fund an international phase III trial for its lead programme, Lupuzor - and speculation about a possible fundraising.

"The board can confirm that the company is adequately funded and has no intention of raising funds," it said.

At 1510 GMT, the shares were up 1.5% at 18.02p.


Email this article to a friend

or share it with one of these popular networks:

Top of Page